<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "https://foliamedica.bg/nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">87</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:A116C711-4C18-5A38-8F1E-5E97753A8A64</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Folia Medica</journal-title>
        <abbrev-journal-title xml:lang="en">FM</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0204-8043</issn>
      <issn pub-type="epub">1314-2143</issn>
      <publisher>
        <publisher-name>Plovdiv Medical University</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3897/folmed.67.e154231</article-id>
      <article-id pub-id-type="publisher-id">154231</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="scientific_subject">
          <subject>Anatomy</subject>
          <subject>Anatomy &amp; Morphology</subject>
          <subject>Pathophysiology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>﻿Examining the relationship between kinesiophobia, quality of life and balance in patients with peripheral vestibular disorders</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Kollia</surname>
            <given-names>Paraskevi</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Agathou</surname>
            <given-names>Konstantina</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Nikitas</surname>
            <given-names>Christos</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Charalambopoulou</surname>
            <given-names>Margarita</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Chytas</surname>
            <given-names>Dimitrios</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0003-2746-7121</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Kyriakidou</surname>
            <given-names>Maria</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Christakou</surname>
            <given-names>Anna</given-names>
          </name>
          <email xlink:type="simple">a.christakou@go.uop.gr</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line>Physiotherapy Department, School of Health Sciences, University of Peloponnese, Sparta, Greece</addr-line>
      </aff>
      <aff id="A2">
        <label>2</label>
        <addr-line>First Department of Otolaryngology, Head and Neck Surgery, National and Kapodistrian University of Athens, Hippocrateion General Hospital, Athens, Greece</addr-line>
      </aff>
      <aff id="A3">
        <label>3</label>
        <addr-line>Division of Audiology/Neurootology, Red Cross Hospital, Athens, Greece</addr-line>
      </aff>
      <aff id="A4">
        <label>4</label>
        <addr-line>Basic Sciences Laboratory, Department of Physiotherapy, School of Health Sciences, University of Peloponnese, Sparta, Greece</addr-line>
      </aff>
      <aff id="A5">
        <label>5</label>
        <addr-line>Biomechanics Laboratory, Physiotherapy Department, School of Health Sciences, University of Peloponnese, Sparta, Greece</addr-line>
      </aff>
      <author-notes>
        <fn fn-type="corresp">
          <p>Corresponding author: Anna Christakou, Department of Physiotherapy, University of Peloponnese, Efstathiou &amp; Stamatikis Valioti and Plataion – 23100, Sparti, Greece; Email: <email xlink:type="simple">a.christakou@go.uop.gr</email></p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2025</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>10</month>
        <year>2025</year>
      </pub-date>
      <volume>67</volume>
      <issue>5</issue>
      <elocation-id>e154231</elocation-id>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/808E41D3-BC0A-5FF6-8FFA-7A246555EA43">808E41D3-BC0A-5FF6-8FFA-7A246555EA43</uri>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>03</month>
          <year>2025</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>06</month>
          <year>2025</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Paraskevi Kollia, Konstantina Agathou, Christos Nikitas, Margarita Charalambopoulou, Dimitrios Chytas, Maria Kyriakidou, Anna Christakou</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>﻿Abstract</label>
        <p><bold>Introduction</bold>: Peripheral vestibular disorders (<abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0EDF">PVDs</abbrev>) are associated with the inner ear or vestibular nerve and can occur as acute, episodic, or persistent vestibular syndromes. The symptoms are mainly vertigo and dizziness, which significantly affect kinesiophobia, quality of life, and balance.</p>
        <p><bold>Aim</bold>: The aim of the present study was to investigate the relationship between kinesiophobia, quality of life, and balance in patients with <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0ELF">PVDs</abbrev>.</p>
        <p><bold>Materials and methods</bold>: The study’s sample population comprised 35 subjects, ranging in age from 30 to 80 years, with a standard deviation of 13.36 years. These subjects were diagnosed with <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0ETF">PVDs</abbrev>. The assessment of kinesiophobia employed the Tampa Scale of Kinesiophobia (<abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0EXF">TSK</abbrev>-GR), while the evaluation of quality of life utilized the EuroQol (EQ-5D-5L and EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0E2F">VAS</abbrev>) scale. The balance of the patient was evaluated using Romberg’s test. Spearman’s r correlation analysis was conducted to examine the relationship between the measured variables.</p>
        <p><bold>Results</bold>: EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0EDG">VAS</abbrev> showed a moderate statistically significant positive correlation with EQ-5D-5L (r=0.51, <italic>p</italic>&lt;0.01). No statistically significant correlation was observed between kinesiophobia, quality of life, and balance.</p>
        <p><bold>Conclusion</bold>: While a significant relationship was found between EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0ENG">VAS</abbrev> and EQ-5D-5L, it is plausible that different factors contributed to the non-statistically significant correlation between the variables of kinesiophobia, balance, and quality of life in patients with <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0ERG">PVDs</abbrev>. Further studies are needed to ascertain the relationship between the above variables to develop effective and individualized rehabilitation programs for patients with <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0EVG">PVDs</abbrev>.</p>
      </abstract>
      <kwd-group>
        <label>Keywords</label>
        <kwd>EQ-5D-5L</kwd>
        <kwd>peripheral vestibular syndromes</kwd>
        <kwd>Romberg test</kwd>
        <kwd>Tampa scale</kwd>
        <kwd>vertigo</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <sec sec-type="Citation" id="SECID0EBH">
        <title>Citation</title>
        <p>Kollia P, Agathou K, Nikitas C, Charalambopoulou M, Chytas D, Kyriakidou M, Christakou A. Examining the relationship between kinesiophobia, quality of life and balance in patients with peripheral vestibular disorders. Folia Med (Plovdiv) 2025;67(5):е154231. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.3897/folmed.67.e154231">10.3897/folmed.67.e154231</ext-link>.</p>
      </sec>
    </notes>
  </front>
  <body>
    <sec sec-type="﻿Introduction" id="SECID0ENH">
      <title>﻿Introduction</title>
      <p>Peripheral vestibular disorders (<abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0ETH">PVDs</abbrev>) involve the vestibular system, particularly the inner ear or vestibular nerve, leading to either acute or persistent vestibular syndromes. <sup>[<xref ref-type="bibr" rid="B1 B2 B3">1–3</xref>]</sup> Key symptoms include vertigo, postural instability, and difficulties with balance during head movements. Common forms of <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0E5H">PVDs</abbrev> are benign paroxysmal positional vertigo (<abbrev xlink:title="benign paroxysmal positional vertigo" id="ABBRID0EDAAC">BBPV</abbrev>), Meniere’s disease, and vestibular neuritis.<sup>[<xref ref-type="bibr" rid="B2">2</xref>]</sup><abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0EOAAC">PVDs</abbrev> are responsible for 44% of dizziness cases, with approximately one-third of acute dizziness episodes linked to peripheral vestibular causes.<sup>[<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>]</sup> Poor compensation for dizziness can exacerbate or prolong symptoms.<sup>[<xref ref-type="bibr" rid="B4">4</xref>]</sup></p>
      <p>Kinesiophobia, the fear of movement due to past trauma, results in both physical and psychological symptoms. This fear leads to restricted movement, reduced physical activity, and a decline in quality of life. It causes excessive concern over movement, anxiety about engaging in physical activities, and further deterioration of strength and fitness due to inactivity.<sup>[<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>]</sup> In elderly patients with <abbrev xlink:title="benign paroxysmal positional vertigo" id="ABBRID0EQBAC">BBPV</abbrev>, fear of falling is a key factor that reduces self-confidence, impairs function, and leads to avoidance of daily activities.<sup>[<xref ref-type="bibr" rid="B8">8</xref>]</sup></p>
      <p>Balance issues are a critical concern in <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0E3BAC">PVDs</abbrev>, as the vestibular system plays a vital role in maintaining balance and spatial orientation. When disrupted, it causes vertigo and imbalance, increasing the risk of falls.<sup>[<xref ref-type="bibr" rid="B9">9</xref>]</sup> Individuals afflicted with vestibular hypofunction often report that their symptoms intensify in circumstances such as darkness or uneven surfaces, where other sensory faculties are unable to provide adequate compensation. However, falls typically occur during daily activities, such as walking or turning. <sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup> Contributing factors to falls in these patients include a sedentary lifestyle, aging, and cognitive impairments.<sup>[<xref ref-type="bibr" rid="B10">10</xref>]</sup></p>
      <p><abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0EWCAC">PVDs</abbrev> significantly impact patients’ quality of life, with symptoms like dizziness and balance disturbances leading to difficulties in daily functioning.<sup>[<xref ref-type="bibr" rid="B1">1</xref>]</sup> The physical strain of maintaining balance, coupled with ongoing dizziness, often results in fatigue and physical decline and may contribute to psychological conditions like anxiety or depression.<sup>[<xref ref-type="bibr" rid="B11 B12 B13">11–13</xref>]</sup> As a result, these factors collectively contribute to a reduced quality of life and increased disability among those affected by <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0EIDAC">PVDs</abbrev>.<sup>[<xref ref-type="bibr" rid="B12">12</xref>]</sup></p>
    </sec>
    <sec sec-type="﻿Aim" id="SECID0ESDAC">
      <title>﻿Aim</title>
      <p>Studies that investigated kinesiophobia in <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0EYDAC">PVDs</abbrev> are limited. To our knowledge, there is no study investigating the association between kinesiophobia, balance, and quality of life in PVD. Therefore, the aim of the present study was to assess the relationship between kinesiophobia, quality of life, and balance in patients in the acute and subacute phases of <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0E3DAC">PVDs</abbrev>.</p>
    </sec>
    <sec sec-type="materials|methods" id="SECID0EAEAC">
      <title>﻿Materials and methods</title>
      <sec sec-type="﻿Design" id="SECID0EEEAC">
        <title>﻿Design</title>
        <p>Cross-sectional survey study.</p>
      </sec>
      <sec sec-type="﻿Participants" id="SECID0EJEAC">
        <title>﻿Participants</title>
        <p>The sample consisted of 35 participants with <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0EPEAC">PVDs</abbrev> (21 women and 14 men), with a mean age of 60.86±13.36 years. The inclusion criteria were (a) patients diagnose d with acute and subacute PVD, (b) patients with symptoms of vertigo, and (c) individuals that are able to understand and speak the Greek language. Patients who had undergone otosurgical procedures have not been excluded from the study. Participants with (a) cognitive deficits, (b) musculoskeletal disorders, and (c) psychiatric conditions were excluded from the study. The study was approved both by the Research Ethics Committee of the University of the Peloponnese (Protocol No. 5360/11-03-2024) and by Athens General Hospital Korgialeneio-Benakeio Hellenic Red Cross (Protocol No. 8721/15-03-2024). The study was conducted in accordance with the Declaration of Helsinki.</p>
      </sec>
      <sec sec-type="﻿Instruments and procedure" id="SECID0ETEAC">
        <title>﻿Instruments and procedure</title>
        <p>The instruments that we used were as follows:</p>
        <sec sec-type="﻿- European Quality of Life (EuroQol [EQ-5D-5L])" id="SECID0EYEAC">
          <title>﻿- <italic>European Quality of Life (EuroQol [EQ-5D-5L])</italic></title>
          <p>The EQ-5D-5L instrument comprises five questions that assess the following five dimensions: (a) mobility, (b) self-care, (c) daily activity, (d) pain (and/or discomfort), and (e) anxiety (and/or depression), respectively. Each question is assigned a score from 1, indicating no problems, to 5, indicating unanswerable. The EQ-visual analogue scale (<abbrev xlink:title="visual analogue scale" id="ABBRID0EAFAC">VAS</abbrev>) ranged from 0, indicating the worst possible state of mental health, to 100, denoting the optimal state. The instrument has been demonstrated to possess both validity and reliability, exhibiting adequate test-retest reliability (ICC=0.65-0.91).<sup>[<xref ref-type="bibr" rid="B14">14</xref>]</sup></p>
        </sec>
        <sec sec-type="﻿- Tampa scale of kinesiophobia (TSK)" id="SECID0EKFAC">
          <title>﻿- <italic>Tampa scale of kinesiophobia (<abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0ERFAC">TSK</abbrev>)</italic></title>
          <p><abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0EXFAC">TSK</abbrev> measures patients’ perception of fear of re-injury. This scale consists of 17 questions related to the subjective assessment of kinesiophobia and is scored from 1 (strongly disagree) to 4 (strongly agree), and the final score is from 17 to 64. Higher scores indicate high fear of movement. This is a valid and reliable test; it has good test-retest reliability (ICC=0.78) and good internal validity (Cronbach’s α=0.74).<sup>[<xref ref-type="bibr" rid="B15">15</xref>]</sup></p>
        </sec>
        <sec sec-type="﻿- Romberg test" id="SECID0EBGAC">
          <title>﻿- <italic>Romberg test</italic></title>
          <p>The Romberg test is a clinical evaluation used to assess an individual’s ability to maintain static balance. The test is performed with the patient standing upright in an attentive position, first with eyes open and then with eyes closed and hands clasped together on the chest. The posture of the person is then compared to a vertical object located behind them. The test is considered positive when the patient exhibits instability or an inability to maintain position. The outcome is considered negative if the patient sustains this position for at least 30 seconds, irrespective of any accompanying sway.<sup>[<xref ref-type="bibr" rid="B16">16</xref>]</sup></p>
          <p>Written informed consent was obtained from all participants, while a form with their demographic data was also filled in. Participants were informed about the process of completing the questionnaires and performing the test, providing clarifications. They were also informed about the procedure and were given appropriate instructions on how to complete the instruments correctly to avoid any errors. The EQ-5D-5L was completed at the beginning of the study in the hospital setting. The <abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0ERGAC">TSK</abbrev> was administered to participants after completing the two questionnaires once at the beginning of the study. The Romberg test was applied to each patient once at the beginning of the study after completing the two questionnaires.</p>
        </sec>
      </sec>
      <sec sec-type="﻿Statistical analyses" id="SECID0EVGAC">
        <title>﻿Statistical analyses</title>
        <p>All statistical analyses were conducted using the Statistical Package for the Social Sciences (SPSS version 29.0, SPSS Inc., Chicago, IL, USA). Descriptive statistics such as mean (M), standard deviation (SD), distribution asymmetry (skewness), minimum (minimum), and maximum (maximum) values were examined. The statistical assumption of normality of the variables was tested using the Shapiro-Wilk normality test, which showed the normality data of participants’ characteristics of kinesiophobia, quality of life, and balance. A Spearman’s r correlation analysis examined the relationship between the variables. We also applied Bonferroni correction to multiple Spearman correlation analyses (thus taming alpha to 0.05/6=0.008) in order to control the probability of making at least one type I error across the multiple correlations.</p>
      </sec>
    </sec>
    <sec sec-type="﻿Results" id="SECID0E1GAC">
      <title>﻿Results</title>
      <p>The characteristics of the samples are presented in <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>. A total of 65.70% of the participants demonstrated proficiency in self-service. Thirty-seven point one percent of the subjects reported no difficulty in daily activities, while forty-two point nine percent reported moderate problems in mobility. The survey revealed that 51.40% of the participants reported experiencing moderate anxiety or depression, while 51.40% reported no discomfort or pain.</p>
      <p><bold>Table <xref ref-type="table" rid="T2">2</xref></bold> shows the mean, standard deviation, minimum and maximum values of the EQ-5D-5L questionnaire, the EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0EOHAC">VAS</abbrev> scale and the <abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0ESHAC">TSK</abbrev>-GR scale. The mean score of the quality of life was 0.69, while the mean score of the EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0EWHAC">VAS</abbrev> of the EQ-5D-5L questionnaire was 73.31 with a maximum possible score of 100. The mean score of kinesiophobia was 38.49 (SD=9.10) indicating the relative existence of kinesiophobia of the sample <bold>(Table <xref ref-type="table" rid="T2">2</xref>)</bold>.</p>
      <p><bold>Table <xref ref-type="table" rid="T3">3</xref></bold> showed a positive statistically significant correlation between the quality of life from the European Quality of Life Questionnaire and the Visual Analogue Scale of the questionnaire (r=0.51, <italic>p</italic>&lt;0.01). No significant correlations were found between kinesiophobia, quality of life, and static balance in patients with <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0ELIAC">PVDs</abbrev>.</p>
      <p><bold>Table <xref ref-type="table" rid="T4">4</xref></bold> presents the p-values of Spearman’s rho correlations between kinesiophobia (<abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0EXIAC">TSK</abbrev>-GR), quality of life (EQ-5D-5L), health status (EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0E2IAC">VAS</abbrev>), and balance (Romberg test). Significant correlation was observed between EQ-5D-5L and EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0E6IAC">VAS</abbrev> (<italic>p</italic>=0.002).</p>
      <table-wrap id="T1" position="float" orientation="portrait">
        <label>Table 1.</label>
        <caption>
          <p>Frequencies and percentages of the demographic data of the sample (n=35)</p>
        </caption>
        <table id="TID0ESIAE" rules="all">
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Sample characteristics</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Frequency</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Percentage of the sample</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Education</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Junior high school</td>
              <td rowspan="1" colspan="1">8</td>
              <td rowspan="1" colspan="1">22.90%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">High school</td>
              <td rowspan="1" colspan="1">11</td>
              <td rowspan="1" colspan="1">31.40%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">University</td>
              <td rowspan="1" colspan="1">14</td>
              <td rowspan="1" colspan="1">40%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Postgraduate</td>
              <td rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1">5.7%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Marital status</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Unmarried</td>
              <td rowspan="1" colspan="1">6</td>
              <td rowspan="1" colspan="1">17.10%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Married</td>
              <td rowspan="1" colspan="1">21</td>
              <td rowspan="1" colspan="1">60%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Divorced</td>
              <td rowspan="1" colspan="1">6</td>
              <td rowspan="1" colspan="1">17.10%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Widow</td>
              <td rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1">5.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Number of children</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">9</td>
              <td rowspan="1" colspan="1">25.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1">11</td>
              <td rowspan="1" colspan="1">31.40%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1">11</td>
              <td rowspan="1" colspan="1">31.40%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1">5.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">4</td>
              <td rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1">5.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Number of comorbidities</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">20</td>
              <td rowspan="1" colspan="1">57.10%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1">9</td>
              <td rowspan="1" colspan="1">25.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">8.60%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1">5.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">4</td>
              <td rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1">2.90%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Number of generic drugs</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">18</td>
              <td rowspan="1" colspan="1">51.40%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1">9</td>
              <td rowspan="1" colspan="1">25.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">8.60%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">8.60%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">4</td>
              <td rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1">2.90%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">8</td>
              <td rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1">2.90%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Previous surgery</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">18</td>
              <td rowspan="1" colspan="1">51.40%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">17</td>
              <td rowspan="1" colspan="1">48.60%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Hospitalization</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">23</td>
              <td rowspan="1" colspan="1">65.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">12</td>
              <td rowspan="1" colspan="1">34.30%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Hypertension</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">12</td>
              <td rowspan="1" colspan="1">34.30%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">23</td>
              <td rowspan="1" colspan="1">65.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3"><bold>Falls</bold> (<bold>last six months</bold>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">9</td>
              <td rowspan="1" colspan="1">25.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">26</td>
              <td rowspan="1" colspan="1">74.30%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Smoking</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">12</td>
              <td rowspan="1" colspan="1">34.30%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">23</td>
              <td rowspan="1" colspan="1">25.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Appearance of vertigo</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">30</td>
              <td rowspan="1" colspan="1">85.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">5</td>
              <td rowspan="1" colspan="1">14.30%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Frequency of vertigo</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">None</td>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">8.60%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Rare</td>
              <td rowspan="1" colspan="1">13</td>
              <td rowspan="1" colspan="1">37.10%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Often</td>
              <td rowspan="1" colspan="1">15</td>
              <td rowspan="1" colspan="1">42.90%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Always</td>
              <td rowspan="1" colspan="1">4</td>
              <td rowspan="1" colspan="1">11.40%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Vertigo medication</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">12</td>
              <td rowspan="1" colspan="1">34.30%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">23</td>
              <td rowspan="1" colspan="1">65.70%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="3">
                <bold>Physiotherapy for vertigo</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Yes</td>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">8.60%</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">No</td>
              <td rowspan="1" colspan="1">32</td>
              <td rowspan="1" colspan="1">91.4%</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="T2" position="float" orientation="portrait">
        <label>Table 2.</label>
        <caption>
          <p>Descriptives of the EQ-5D-5L, EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0EK2AE">VAS</abbrev>, <abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0EO2AE">TSK</abbrev>-GR instruments and Shapiro-Wilk <italic>p</italic>-values</p>
        </caption>
        <table id="TID0EQDAG" rules="all">
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Instruments</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>M</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>SD</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Minimum</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Maximum</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Skewness</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Kurtosis</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>p-values</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Median</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>IQR</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">EQ-5D-5L <bold><sup>†</sup></bold></td>
              <td rowspan="1" colspan="1">0.69</td>
              <td rowspan="1" colspan="1">0.31</td>
              <td rowspan="1" colspan="1">−0.36</td>
              <td rowspan="1" colspan="1">1.00</td>
              <td rowspan="1" colspan="1">−1.96</td>
              <td rowspan="1" colspan="1">3.74</td>
              <td rowspan="1" colspan="1">&lt;0.001</td>
              <td rowspan="1" colspan="1">0.806</td>
              <td rowspan="1" colspan="1">0.260</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0E35AE">VAS</abbrev><bold><sup>‡</sup></bold></td>
              <td rowspan="1" colspan="1">73.31</td>
              <td rowspan="1" colspan="1">17.11</td>
              <td rowspan="1" colspan="1">30</td>
              <td rowspan="1" colspan="1">100</td>
              <td rowspan="1" colspan="1">1.01</td>
              <td rowspan="1" colspan="1">0.48</td>
              <td rowspan="1" colspan="1">0.04</td>
              <td rowspan="1" colspan="1">80.00</td>
              <td rowspan="1" colspan="1">20</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"><abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0EDAAG">TSK</abbrev>-GR <bold><sup>‡‡</sup></bold></td>
              <td rowspan="1" colspan="1">38.49</td>
              <td rowspan="1" colspan="1">9.10</td>
              <td rowspan="1" colspan="1">62</td>
              <td rowspan="1" colspan="1">26</td>
              <td rowspan="1" colspan="1">−0.67</td>
              <td rowspan="1" colspan="1">−0.22</td>
              <td rowspan="1" colspan="1">0.007</td>
              <td rowspan="1" colspan="1">36.00</td>
              <td rowspan="1" colspan="1">11</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>† EQ-5D-5L: European Quality of Life Questionnaire; ‡ EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0EIBAG">VAS</abbrev>: visual analogue scale; ‡‡ <abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0EMBAG">TSK</abbrev>-GR: Tampa Scale of Kinesiophobia</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="T3" position="float" orientation="portrait">
        <label>Table 3.</label>
        <caption>
          <p>Spearman’s r correlations between kinesiophobia, quality of life, EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0EZBAG">VAS</abbrev> and balance</p>
        </caption>
        <table id="TID0E3KAG" rules="all">
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Instruments</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold><abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0EOCAG">TSK</abbrev>-GR</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>EQ-5D-5L</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0E6CAG">VAS</abbrev></bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Romberg test</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"><abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0EODAG">TSK</abbrev>-GR <sup>†</sup></td>
              <td rowspan="1" colspan="1">1.00</td>
              <td rowspan="1" colspan="1">−0.12</td>
              <td rowspan="1" colspan="1">−0.10</td>
              <td rowspan="1" colspan="1">−0.08</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">EQ-5D-5L <sup>‡</sup></td>
              <td rowspan="1" colspan="1">−0.12</td>
              <td rowspan="1" colspan="1">1.00</td>
              <td rowspan="1" colspan="1">0.51**</td>
              <td rowspan="1" colspan="1">0.08</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0EWEAG">VAS</abbrev><sup>‡‡</sup></td>
              <td rowspan="1" colspan="1">−0.10</td>
              <td rowspan="1" colspan="1">0.51**</td>
              <td rowspan="1" colspan="1">1.00</td>
              <td rowspan="1" colspan="1">0.27</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Romberg’s test</td>
              <td rowspan="1" colspan="1">−0.08</td>
              <td rowspan="1" colspan="1">0.08</td>
              <td rowspan="1" colspan="1">0.27</td>
              <td rowspan="1" colspan="1">1.00</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>† <abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0E2FAG">TSK</abbrev>-GR: Tampa scale of kinesiophobia; ‡ EQ-5D-5L: European Quality of Life Questionnaire; ‡‡ EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0E6FAG">VAS</abbrev>: Visual Analogue Scale; **<italic>p</italic>&lt;0.01</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="T4" position="float" orientation="portrait">
        <label>Table 4.</label>
        <caption>
          <p>P-value of Spearman’s <italic>rho</italic> correlations between kinesiophobia, quality of life, EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0EQGAG">VAS</abbrev> and balance</p>
        </caption>
        <table id="TID0EHQAG" rules="all">
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
                <bold>Instruments</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold><abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0EFHAG">TSK</abbrev>-GR</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>EQ-5D-5L</bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0EWHAG">VAS</abbrev></bold>
              </td>
              <td rowspan="1" colspan="1">
                <bold>Romberg’s test</bold>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"><abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0EFIAG">TSK</abbrev>-GR <bold><sup>†</sup></bold></td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">0.487</td>
              <td rowspan="1" colspan="1">0.562</td>
              <td rowspan="1" colspan="1">0.630</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">EQ-5D-5L <bold><sup>‡</sup></bold></td>
              <td rowspan="1" colspan="1">0.487</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">0.002**</td>
              <td rowspan="1" colspan="1">0.630</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0EPJAG">VAS</abbrev><bold><sup>‡‡</sup></bold></td>
              <td rowspan="1" colspan="1">0.562</td>
              <td rowspan="1" colspan="1">0.002**</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">0.112</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Romberg’s test</td>
              <td rowspan="1" colspan="1">0.630</td>
              <td rowspan="1" colspan="1">0.084</td>
              <td rowspan="1" colspan="1">0.112</td>
              <td rowspan="1" colspan="1">-</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>† <abbrev xlink:title="Tampa scale of kinesiophobia" id="ABBRID0EVKAG">TSK</abbrev>-GR: Tampa scale of kinesiophobia; ‡ EQ-5D-5L: European Quality of Life Questionnaire; ‡‡ EQ-<abbrev xlink:title="visual analogue scale" id="ABBRID0EZKAG">VAS</abbrev>: Visual Analogue Scale; **<italic>p</italic>&lt;0.01</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec sec-type="﻿Discussion" id="SECID0EFJAC">
      <title>﻿Discussion</title>
      <p>The aim of the study was to investigate the relationship between kinesiophobia, quality of life, and balance in patients that have been diagnosed with a PVD, were in the subacute stage of the disease, and had symptoms of vertigo.</p>
      <p>The results showed a significant correlation between the EQ-5D-5L and the EQ-5D <abbrev xlink:title="visual analogue scale" id="ABBRID0EMJAC">VAS</abbrev>. The results of patients’ responses to mobility, self-care, usual activities, pain or discomfort, and anxiety or depression were significantly correlated with their responses to the subjective assessment of their health status based on the EQ-5D <abbrev xlink:title="visual analogue scale" id="ABBRID0EQJAC">VAS</abbrev>. Similarly, Golicki et al.<sup>[<xref ref-type="bibr" rid="B17">17</xref>]</sup> found correlations between the EQ-5D-5L and the EQ-5D <abbrev xlink:title="visual analogue scale" id="ABBRID0E2JAC">VAS</abbrev> in stroke patients. The mean changes in the 3L version of the EQ-5D-5L were greater than the mean changes in the 5L version, and the latter was greater than the mean changes in the 5Q-5D <abbrev xlink:title="visual analogue scale" id="ABBRID0E6JAC">VAS</abbrev>. Correlations showed that changes in the 5L version of the EQ-5D-5L had a statistically significant correlation with changes in the 3L version and showed a moderate correlation with changes in the EQ-5D <abbrev xlink:title="visual analogue scale" id="ABBRID0EDKAC">VAS</abbrev>.</p>
      <p>In this study, no significant correlations were found between kinesiophobia, quality of life, and static balance in patients with <abbrev xlink:title="Peripheral vestibular disorders" id="ABBRID0EJKAC">PVDs</abbrev>, likely due to multiple factors related to disease, patient demographics, or external influences. Vestibular function is complex and multifactorial, significantly impacting quality of life. Although balance assessment via the Romberg test indicated adequate ability typical in unilateral vestibular dysfunction, chronic conditions like persistent postural perceptual dizziness may distort patients’ perception of static balance due to maladaptive plasticity. <sup>[<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>]</sup> Furthermore, different types of vestibular pathology affect these factors differently, with bilateral cases posing a higher fall risk than unilateral ones.<sup>[<xref ref-type="bibr" rid="B20">20</xref>]</sup></p>
      <p>The study’s results may vary depending on the stage of the disorder, as patient adaptation and vestibular compensation progress. Clinicians often focus on measurable parameters, which may explain the previously underrecognized cognitive deficits in patients with peripheral vestibular disorders.<sup>[<xref ref-type="bibr" rid="B21">21</xref>]</sup> This justified the inclusion of kinesiophobia as an outcome measure. Some variables like kinesiophobia, quality of life, and balance might not be directly influenced by the disorder but rather by chronic conditions.<sup>[<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>]</sup> For example, balance issues are common in older adults and considered a geriatric syndrome with multifactorial causes, increasing vulnerability to daily life challenges.<sup>[<xref ref-type="bibr" rid="B24">24</xref>]</sup> This complexity and symptom adaptation may explain the lack of significant correlations among the study variables.</p>
      <p>Antihistamines, antiemetics, and antivertigo drugs suppress vestibular activity and relieve symptoms for 4-12 hours in PVD patients.<sup>[<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>]</sup> After a vestibular lesion, imbalance between the affected and unaffected ear is managed by suppressing both sides, which may also reduce the overall vestibular function. However, vertigo acts as essential sensory feedback for brain compensation, so symptom suppression can hinder recovery. Thus, reducing dizziness and promoting compensation are often conflicting goals. <sup>[<xref ref-type="bibr" rid="B25">25</xref>]</sup> Despite this, static balance seemed unaffected in participants, suggesting that testing on unstable surfaces or with dynamic gait assessments may be more informative. <sup>[<xref ref-type="bibr" rid="B27">27</xref>]</sup> Additionally, polypharmacy may disrupt balance and worsen symptoms, potentially influencing kinesiophobia outcomes.<sup>[<xref ref-type="bibr" rid="B24">24</xref>]</sup> This may have affected the results of the assessment of kinesiophobia.</p>
      <p>In the present study, 60% of the respondents were females. Petri et al.<sup>[<xref ref-type="bibr" rid="B11">11</xref>]</sup> observed female mastery at 72%. This is attributed to a variety of causes, such as menopause, osteoporosis, cardiovascular problems, and hormonal changes that can cause vertigo. Obermann et al.<sup>[<xref ref-type="bibr" rid="B28">28</xref>]</sup> claimed that selection bias of older women may affect the study outcomes. Future studies should be conducted with more homogenous samples regarding the sex of the participants. Furthermore, both Lucieer et al.<sup>[<xref ref-type="bibr" rid="B21">21</xref>]</sup> and the present study were unable to determine whether the severity of symptoms was related to the advanced age of the participants.</p>
      <p>A large proportion of the sample in the present study had received canalith repositioning maneuvers (CRM) before their assessment, which could have influenced the results. Patients with paroxysmal positional vertigo may benefit from these maneuvers. A significant improvement in symptoms is observed after CRM, demonstrating the beneficial effects of the treatment even in people without objective evidence of paroxysmal positional vertigo.<sup>[<xref ref-type="bibr" rid="B29">29</xref>]</sup> In addition, CRM treatment improves health-related quality of life, particularly in the physical domain.<sup>[<xref ref-type="bibr" rid="B30">30</xref>]</sup></p>
      <sec sec-type="﻿Limitations and future recommendations" id="SECID0EBOAC">
        <title>﻿Limitations and future recommendations</title>
        <p>The present study has several limitations. There are potential confounders that may influence our results. These include demographic factors (age, sex, and education), clinical factors (symptom duration, disorder type, and severity), comorbidities (diabetes and hypertension), psychological and social factors (anxiety, depression, past falls, and social support), pharmacological factors (medications affecting CNS or vestibular function), as well as functional status and activity levels (physical activity and prior vestibular rehabilitation). In particular, the study was limited due to the small convenience sample size. This makes it difficult to generalize the results to the general population and to other vestibular disorders of central etiology. The sample was unevenly balanced between male and female participants, making it difficult to make gender comparisons with regard to the variables studied. Another limitation is that the mean age of the sample was 60.86 years, with younger age groups (&gt;30 years) being absent from the study, and the physical activity levels of the participants were not assessed. Therefore, the sample was heterogeneous with different comorbidities. Some patients also received both general medication and vertigo treatment, which may influence the results of the study. Also, the present study did not examine the risk of falls or dynamic postural disturbances. In addition, the questionnaires used to assess vestibular deficits in quality of life have not been developed enough to fully address the range of symptoms that affect the quality of life in patients with bilateral vestibulopathy.<sup>[<xref ref-type="bibr" rid="B22">22</xref>]</sup> Therefore, the use of the EQ-5D-5L and the EQ-5D <abbrev xlink:title="visual analogue scale" id="ABBRID0EOOAC">VAS</abbrev> to evaluate the quality of life of the patients in the present study probably did not properly cover all of the affected domains. Last but equally important is the fact that it was not investigated whether the occurrence of kinesiophobia, quality of life, and balance differed according to the cause of PVD.</p>
        <p>Future research should be conducted using other valid and reliable instruments of quality of life in this clinical population. Also, studies should employ a larger sample, including both older and younger patients. The causes leading to the occurrence of PVD mainly in women and the effect of gender on the study variables should be investigated. Further research using more complex tests, such as the modified Romberg test to assess balance, is likely to provide more information about balance impairments in these patients. Finally, it seems necessary to conduct a future study that will include labyrinth function by an audiologist and examine the variables in acute, subacute, and chronic stages in separate study groups with the same PVD. This will provide results on the level and intensity in which each disorder affects the factors of kinesiophobia, quality of life, and balance.</p>
      </sec>
    </sec>
    <sec sec-type="﻿Conclusion" id="SECID0ETOAC">
      <title>﻿Conclusion</title>
      <p>The results of the present study showed a statistically significant correlation between quality-of-life variables but no other correlations between kinesiophobia, balance, and quality of life. Future studies with a larger sample size, equal participation of women and men, and a wider age range will provide a successful generalization of the results to the population. The use of modified tests to assess balance by examining parameters such as tremor and sway, which are critical factors in maintaining upright posture, will provide additional evidence on the impact of PVD on balance. Understanding the correlation between these factors will enhance the development of appropriate rehabilitation methods, improving the overall health status of this clinical population</p>
    </sec>
    <sec sec-type="﻿Disclosures" id="SECID0EYOAC">
      <title>﻿Disclosures</title>
      <sec sec-type="﻿Human subjects" id="SECID0E3OAC">
        <title>﻿Human subjects</title>
        <p>Consent for treatment and open access publication was obtained or waived by all participants in this study. The Ethics Committee of the University of Peloponnese and the Athens General Hospital Korgialeneio-Benakeio Hellenic Red Cross issued approval for Protocol number 5360/11-03-2024 and Protocol number 8721/15-03-2024. Hellenic Republic University of the Peloponnese School of Health Sciences.</p>
      </sec>
      <sec sec-type="﻿Ethics and Research Committee" id="SECID0EBPAC">
        <title>﻿Ethics and Research Committee</title>
        <p>The Ethics and Research Committee convened in Tripoli on March 8, 2024. Subject: Approval of the research protocol on “Examining the relationship between kinesiophobia factors, quality of life, and balance in patients with peripheral vestibular disorders.” Supervisor: Professor Anna Christakou, Professor of the Department of Physical Therapy, UOP. Researchers: Konstantina Agathou and Paraskevi Kollia are undergraduate students enrolled in the Department of Physical Therapy at the University of Peloponnese (UOP). It is imperative that researchers adhere to the principles of the Declaration of Helsinki, as well as to the applicable national and international legislation on the protection of personal data in research. In addition, compliance with the Code of Ethics of the School of Health Sciences of the University of Peloponnese is a prerequisite for conducting research. For the Committee, Eustathios Selimis, Associate Professor, University of Peloponnese, School of Health Sciences, Faculty of Economics building, 2nd floor, Shechi Tripoli, Postal code 22100.</p>
        <p>Committee Members: Argyri Constantina, Assistant Professor, Member; Kurlaba Georgia, Assistant Professor, Member; Kyriakidou Maria, Assistant Professor, Member; Selimi Eustathios, Associate Professor, President.</p>
      </sec>
      <sec sec-type="﻿Animal subjects" id="SECID0EHPAC">
        <title>﻿Animal subjects</title>
        <p>All authors have confirmed that this study did not involve animal subjects or tissue.</p>
      </sec>
    </sec>
    <sec sec-type="﻿Conflicts of interest" id="SECID0EMPAC">
      <title>﻿Conflicts of interest</title>
      <p>In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</p>
    </sec>
    <sec sec-type="﻿Author contributions" id="SECID0ERPAC">
      <title>﻿Author contributions</title>
      <p>Conceptualization: A.C.; methodology: P.K., K.A., C.N., M.C., and A.C.; investigation: P.K. and K.A.; data curation: P.K. and K.A.; writing—original draft preparation: P.K., K.A., and A.C.; writing—review and editing: P.K., K.A., C.N., M.C., and A.C.; supervision: A.C. All authors have read and agreed to the published version of the manuscript.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>﻿Acknowledgements</title>
      <p>We would like to thank our participants for taking part in the present study.</p>
    </ack>
    <ref-list>
      <title>﻿References</title>
      <ref id="B1">
        <mixed-citation xlink:type="simple">1. McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev 2015; 1(1):CD005397. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1002/14651858.CD005397.pub4">10.1002/14651858.CD005397.pub4</ext-link></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation xlink:type="simple">2. Strupp M, Brandt T. Peripheral vestibular disorders. Curr Opin Neurol 2013; 26(1):81–9. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1097/WCO.0b013e32835c5fd4">10.1097/WCO.0b013e32835c5fd4</ext-link></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation xlink:type="simple">3. Strupp M, Dlugaiczyk J, Ertl-Wagner BB, et al. Vestibular disorders: diagnosis, new classification and treatment. Dtsch Arztebl Int 2020; 117(17):300. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.3238/arztebl.2020.0300">10.3238/arztebl.2020.0300</ext-link></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation xlink:type="simple">4. Magnusson M, Karlberg M. Peripheral vestibular disorders with acute onset of vertigo. Curr Opin Neurol 2002; 15(1):5–10.</mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation xlink:type="simple">5. Hall CD, Herdman SJ, Whitney SL, et al. Vestibular rehabilitation for peripheral vestibular hypofunction: an updated clinical practice guideline from the Academy of Neurologic Physical Therapy of the American Physical Therapy Association. J Neurol Phys Ther 2022; 46(2). doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1097/00019052-200202000-00002">10.1097/00019052-200202000-00002</ext-link></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation xlink:type="simple">6. Sever E, Kiliç G, Algun ZC. The effects of vestibular rehabilitation on kinesiophobia and balance with individuals who has vestibular hypofunction. Indian J Otolaryngol Head Neck Surg 2021; 74(S3). doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1007/s12070-021-02979-x">10.1007/s12070-021-02979-x</ext-link></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation xlink:type="simple">7. Scifers JR, Stiller-Ostrowski J, Granquist MD, et al. Kinesiophobia. Athletic Training; Sports Health Care 2014; 6(6):248–51. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.3928/19425864-20141125-12">10.3928/19425864-20141125-12</ext-link></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation xlink:type="simple">8. Pauwels S, Casters L, Lemkens N, et al. Gait and falls in benign paroxysmal positional vertigo: a systematic review and meta-analysis. J Neurol Phys Ther 2023; 47(3):127–38. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1097/NPT.0000000000000438">10.1097/NPT.0000000000000438</ext-link></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation xlink:type="simple">9. Mancini M, Horak FB. The relevance of clinical balance assessment tools to differentiate balance deficits. Eur J Phys Rehabil Med 2010; 46(2):239, PMID: <ext-link xlink:type="simple" ext-link-type="pmid" xlink:href="20485226">20485226</ext-link>.</mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation xlink:type="simple">10. Wuehr M, Decker J, Schenkel F, et al. Impact on daily mobility and risk of falling in bilateral vestibulopathy. J Neurol 2022; 269(11):5746–54. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1007/s00415-022-11043-9">10.1007/s00415-022-11043-9</ext-link></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation xlink:type="simple">11. Petri M, Chirilă M, Bolboacă SD, et al. Health-related quality of life and disability in patients with acute unilateral peripheral vestibular disorders. Brazilian J Otorhinolaryngol 2017; 83(6):611–8. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1016/j.bjorl.2016.08.004">10.1016/j.bjorl.2016.08.004</ext-link></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation xlink:type="simple">12. Mira E. Improving the quality of life in patients with vestibular disorders: the role of medical treatments and physical rehabilitation. Int J Clin Prac 2007; 62(1):109–14. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1111/j.1742-">10.1111/j.1742-</ext-link> 1241.2006.01091.x</mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation xlink:type="simple">13. Molnár A, Maihoub S, Mavrogeni P, et al. Depression scores and quality of life of vertiginous patients, suffering from different vestibular disorders. Eur Arch Oto-Rhino-Laryngol 2022; 279(11):5173–9. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1007/s00405-022-07366-y">10.1007/s00405-022-07366-y</ext-link></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation xlink:type="simple">14. Long D, Polinder S, Bonsel GJ, et al. Test-retest reliability of the EQ-5D-5L and the reworded QOLIBRI-OS in the general population of Italy, the Netherlands, and the United Kingdom. Qual Life Res 2021; 30(10):2961–71. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1007/s11136-021-02893-3">10.1007/s11136-021-02893-3</ext-link></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation xlink:type="simple">15. Georgoudis G, Raptis K, Koutserimpas C. Cognitive assessment of musculoskeletal pain: validity and reliability of the Greek version of the Tampa scale of kinesiophobia in patients suffering from chronic low back pain. Maedica 2022; 17(4):826–32. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.26574/maedica.2022.17.4.826">10.26574/maedica.2022.17.4.826</ext-link></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation xlink:type="simple">16. Panjan A, Sarabon N. Review of methods for the evaluation of human bo-dy balance. Sport Sci Rev 2010; 19(5-6). doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.2478/v10237-011-0036-5">10.2478/v10237-011-0036-5</ext-link></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation xlink:type="simple">17. Golicki D, Niewada M, Karlińska A, et al. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L, and EQ VAS in stroke patients. Qual Life Res 2014; 24(6):1555–63. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1007/s11136-014-0873-7">10.1007/s11136-014-0873-7</ext-link></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation xlink:type="simple">18. Halmágyi GM, Curthoys IS. Vestibular contributions to the Romberg test: Testing semicircular canal and otolith function. Eur J Neurol 2021; 28(9):3211–9. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1111/ene.14942">10.1111/ene.14942</ext-link></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation xlink:type="simple">19. Castro P, Papoutselou E, Mahmoud S, et al. Priming overconfidence in belief systems reveals negative return on postural control mechanisms. Gait and Posture 2022; 94:1–8. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1016/j.gaitpost.2022.02.015">10.1016/j.gaitpost.2022.02.015</ext-link></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation xlink:type="simple">20. Herssens N, Dobbels B, Moyaert J, et al. Paving the way toward distinguishing fallers from non-fallers in bilateral vestibulopathy: a wide pilot observation. Front Neurol 2021; 12. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.3389/fneur.2021.611648">10.3389/fneur.2021.611648</ext-link></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation xlink:type="simple">21. Nikitas C, Kontogianni E, Papadopoulou S, et al. Can vigilance predict the status of safe functional gait and risk of falls in patients with peripheral vestibular disorders? A cross-sectional study. J Neurol Sci 2023; 445:120547–7. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1016/j.jns.2023.120547">10.1016/j.jns.2023.120547</ext-link></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation xlink:type="simple">22. Lucieer FMP, Van Hecke R, van Stiphout L, et al. Bilateral vestibulopathy: beyond imbalance and oscillopsia. J Neurol 2020; 267(S1):241–55. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1007/s00415-020-10243-5">10.1007/s00415-020-10243-5</ext-link></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation xlink:type="simple">23. Sanchez-Cuadrado I, Calvino M, Morales-Puebla JM, et al. Quality of life following cochlear implantation in patients with Menière’s disease. Front Neurol 2021; 12. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.3389/fneur.2021.670137">10.3389/fneur.2021.670137</ext-link></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation xlink:type="simple">24. Sousa R, Gazzola JM, Ganança MM, et al. [Correlation between the body balance and functional capacity from elderly with chronic vestibular disorders]. Braz J Otorhinolaryngol 2011; 77(6):791–8. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1590/S1808-86942011000600017">10.1590/S1808-86942011000600017</ext-link> [Portuguese].</mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation xlink:type="simple">25. Rascol O, Hain TC, Brefel C, et al. Antivertigo medications and drug-induced vertigo. Drugs 1995; 50(5):777–91. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.2165/00003495-199550050-00002">10.2165/00003495-199550050-00002</ext-link></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation xlink:type="simple">26. Scholtz AW, Hahn A, Stefflova B, et al. Efficacy and safety of a fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg vs betahistine dihydrochloride 16 mg in patients with peripheral vestibular vertigo: a prospective, multinational, multicenter, double-blind, randomized, non-inferiority clinical trial. Clin Drug Investig 2019; 39(11):1045–56. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1007/s40261-019-00858-6">10.1007/s40261-019-00858-6</ext-link></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation xlink:type="simple">27. Wrisley DM, Marchetti GF, Kuharsky DK, et al. Reliability, internal consistency, and validity of data obtained with the functional gait assessment. Phys Ther 2004; 84(10):906–18.</mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation xlink:type="simple">28. Obermann M, Bock E, Sabev N, et al. Long-term outcome of vertigo and dizziness associated disorders following treatment in specialized tertiary care: the Dizziness and Vertigo Registry (DiVeR) Study. J Neurol 2015; 262(9):2083–91. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1007/s00415-015-7803-7">10.1007/s00415-015-7803-7</ext-link></mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation xlink:type="simple">29. Huebner AC, Lytle SR, Doettl SM, et al. Treatment of objective and subjective benign paroxysmal positional vertigo. J Am Acad Audiol 2013; 24(07):600–6. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.3766/jaaa.24.7.8">10.3766/jaaa.24.7.8</ext-link></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation xlink:type="simple">30. López-Escámez JA, Gómez Fiñana M, Fernández A, et al. [Assesement of treatment for benign paroxysmal positional vertigo with the Dhi-S questionnaire]. Acta Otorrinolaringológica Española 2001; 52(8):660–6. doi: <ext-link xlink:type="simple" ext-link-type="doi" xlink:href="10.1016/s0001-6519(01)78263-5">10.1016/s0001-6519(01)78263-5</ext-link> [Spanish].</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
